These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10403826)

  • 41. Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol.
    Koide K; Bunnage ME; Gomez Paloma L; Kanter JR; Taylor SS; Brunton LL; Nicolaou KC
    Chem Biol; 1995 Sep; 2(9):601-8. PubMed ID: 9383464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunosuppressive activity of daphnetin, one of coumarin derivatives, is mediated through suppression of NF-κB and NFAT signaling pathways in mouse T cells.
    Song B; Wang Z; Liu Y; Xu S; Huang G; Xiong Y; Zhang S; Xu L; Deng X; Guan S
    PLoS One; 2014; 9(5):e96502. PubMed ID: 24800925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Inhibitory effects of 11 coumarin compounds against growth of human bladder carcinoma cell line E-J in vitro].
    Yang XW; Xu B; Ran FX; Wang RQ; Wu J; Cui JR
    Zhong Xi Yi Jie He Xue Bao; 2007 Jan; 5(1):56-60. PubMed ID: 17214937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific inhibition of cyclic AMP-dependent protein kinase by warangalone and robustic acid.
    Wang BH; Ternai B; Polya G
    Phytochemistry; 1997 Mar; 44(5):787-96. PubMed ID: 9115691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daphnetin, a Coumarin in Genus Stellera Chamaejasme Linn: Chemistry, Bioactivity and Therapeutic Potential.
    Hang S; Wu W; Wang Y; Sheng R; Fang Y; Guo R
    Chem Biodivers; 2022 Sep; 19(9):e202200261. PubMed ID: 35880614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing the inhibition of protein kinases.
    Brockhoff M; Hau JC; Fontana P; Zimmermann C; Pover AD; Erdmann D; Chène P
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):194-200. PubMed ID: 21635207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity-based kinase profiling of approved tyrosine kinase inhibitors.
    Kitagawa D; Yokota K; Gouda M; Narumi Y; Ohmoto H; Nishiwaki E; Akita K; Kirii Y
    Genes Cells; 2013 Feb; 18(2):110-22. PubMed ID: 23279183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro inhibition effect of some coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Gokce B; Gencer N; Arslan O; Karatas MO; Alici B
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):534-7. PubMed ID: 25982292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases.
    Hagiwara M; Inoue S; Tanaka T; Nunoki K; Ito M; Hidaka H
    Biochem Pharmacol; 1988 Aug; 37(15):2987-92. PubMed ID: 3164998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives.
    Yang EB; Guo YJ; Zhang K; Chen YZ; Mack P
    Biochim Biophys Acta; 2001 Dec; 1550(2):144-52. PubMed ID: 11755203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L.
    Masamoto Y; Ando H; Murata Y; Shimoishi Y; Tada M; Takahata K
    Biosci Biotechnol Biochem; 2003 Mar; 67(3):631-4. PubMed ID: 12723615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
    Woo LW; Purohit A; Reed MJ; Potter BV
    J Med Chem; 1996 Mar; 39(7):1349-51. PubMed ID: 8691463
    [No Abstract]   [Full Text] [Related]  

  • 53. Mapping the ATP-binding domain of DNA-dependent protein kinase (DNA-PK) with coumarin- and isocoumarin-derived inhibitors.
    Payne SL; Rodriguez-Aristegui S; Bardos J; Cano C; Golding BT; Hardcastle IR; Peacock M; Parveen N; Griffin RJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3649-53. PubMed ID: 20472428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural requirements of hydroxylated coumarins for in vitro anti-Helicobacter pylori activity.
    Kawase M; Tanaka T; Sohara Y; Tani S; Sakagami H; Hauer H; Chatterjee SS
    In Vivo; 2003; 17(5):509-12. PubMed ID: 14598616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition kinetics and selectivity of the tyrosine kinase inhibitor erbstatin and a pyridone-based analogue.
    Hsu CY; Jacoski MV; Maguire MP; Spada AP; Zilberstein A
    Biochem Pharmacol; 1992 Jun; 43(11):2471-7. PubMed ID: 1319162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.
    Karataş MO; Uslu H; Alıcı B; Gökçe B; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1386-91. PubMed ID: 26887799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC).
    Zimmermann J; Caravatti G; Mett H; Meyer T; Müller M; Lydon NB; Fabbro D
    Arch Pharm (Weinheim); 1996 Jul; 329(7):371-6. PubMed ID: 8764886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determining appropriate substrate conversion for enzymatic assays in high-throughput screening.
    Wu G; Yuan Y; Hodge CN
    J Biomol Screen; 2003 Dec; 8(6):694-700. PubMed ID: 14711395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of prostaglandin biosynthesis by coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin.
    Lee RE; Bykadi G; Ritschel WA
    Arzneimittelforschung; 1981; 31(4):640-2. PubMed ID: 7195710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Syntheses and evaluation of daphnetin derivatives as novel G protein-coupled receptor inhibitors and activators.
    Wang Y; Wang J; Fu Z; Sheng R; Wu W; Fan J; Guo R
    Bioorg Chem; 2020 Nov; 104():104342. PubMed ID: 33142412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.